247 related articles for article (PubMed ID: 20663970)
1. Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation.
Edward M; Quinn JA; Burden AD; Newton BB; Jardine AG
Radiology; 2010 Sep; 256(3):735-43. PubMed ID: 20663970
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium contrast agent associated stimulation of human fibroblast collagen production.
MacNeil S; Bains S; Johnson C; Idée JM; Factor C; Jestin G; Fretellier N; Morcos SK
Invest Radiol; 2011 Nov; 46(11):711-7. PubMed ID: 21826007
[TBL] [Abstract][Full Text] [Related]
3. Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis.
Edward M; Quinn JA; Mukherjee S; Jensen MB; Jardine AG; Mark PB; Burden AD
J Pathol; 2008 Apr; 214(5):584-93. PubMed ID: 18220317
[TBL] [Abstract][Full Text] [Related]
4. Incidence of immediate gadolinium contrast media reactions.
Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
Altun E; Martin DR; Wertman R; Lugo-Somolinos A; Fuller ER; Semelka RC
Radiology; 2009 Dec; 253(3):689-96. PubMed ID: 19789233
[TBL] [Abstract][Full Text] [Related]
6. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
7. Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.
Soulez G; Bloomgarden DC; Rofsky NM; Smith MP; Abujudeh HH; Morgan DE; Lichtenstein RJ; Schiebler ML; Wippold FJ; Russo C; Kuhn MJ; Mennitt KW; Maki JH; Stolpen A; Liou J; Semelka RC; Kirchin MA; Shen N; Pirovano G; Spinazzi A
AJR Am J Roentgenol; 2015 Sep; 205(3):469-78. PubMed ID: 26295633
[TBL] [Abstract][Full Text] [Related]
8. Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts.
Ozawa Y; Hayashi S; Hamasaki Y; Hatamochi A
Arch Dermatol Res; 2016 Dec; 308(10):695-701. PubMed ID: 27683230
[TBL] [Abstract][Full Text] [Related]
9. Skin gadolinium following use of MR contrast agents in a rat model of nephrogenic systemic fibrosis.
Haylor J; Schroeder J; Wagner B; Nutter F; Jestin G; Idée JM; Morcos S
Radiology; 2012 Apr; 263(1):107-16. PubMed ID: 22344402
[TBL] [Abstract][Full Text] [Related]
10. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
[TBL] [Abstract][Full Text] [Related]
11. Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.
Edwards BJ; Laumann AE; Nardone B; Miller FH; Restaino J; Raisch DW; McKoy JM; Hammel JA; Bhatt K; Bauer K; Samaras AT; Fisher MJ; Bull C; Saddleton E; Belknap SM; Thomsen HS; Kanal E; Cowper SE; Abu Alfa AK; West DP
Br J Radiol; 2014 Oct; 87(1042):20140307. PubMed ID: 25230161
[TBL] [Abstract][Full Text] [Related]
12. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
[TBL] [Abstract][Full Text] [Related]
13. Neurotolerability of gadobenate dimeglumine. Evaluation of brain dopamine concentration in freely moving rats by microdialysis.
La Noce A; Frigeni V; Filatori I; Danieli A; Tirone P
Invest Radiol; 1999 Aug; 34(8):543-7. PubMed ID: 10434187
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study.
Heinrich MC; Kuhlmann MK; Kohlbacher S; Scheer M; Grgic A; Heckmann MB; Uder M
Radiology; 2007 Feb; 242(2):425-34. PubMed ID: 17179401
[TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effects of recently developed monomer and dimer magnetic resonance imaging contrast media: a comparative study.
Geschwind JF; Saeed M; Wendland MF; Szolar D; Derugin N; Higgins CB
Acad Radiol; 1996 Aug; 3(8):667-77. PubMed ID: 8796731
[TBL] [Abstract][Full Text] [Related]
16. Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMA's Pharmacovigilance and Risk Assessment Committee Recommendation for Suspension of the Marketing Authorizations for 4 Linear Agents.
Runge VM
Invest Radiol; 2017 Jun; 52(6):317-323. PubMed ID: 28368880
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
Cheong BY; Duran C; Preventza OA; Muthupillai R
AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging.
Di Gregorio E; Furlan C; Atlante S; Stefania R; Gianolio E; Aime S
Invest Radiol; 2020 Jan; 55(1):30-37. PubMed ID: 31503081
[TBL] [Abstract][Full Text] [Related]
20. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents.
Maki JH; Wang M; Wilson GJ; Shutske MG; Leiner T
J Magn Reson Imaging; 2009 Nov; 30(5):1085-92. PubMed ID: 19856442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
